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Abstract

The objective of the proposed study is to develop new materials and methods to
manage microbial growth in chronic wounds using phototherapy. Chronic wounds are
considered as a worldwide health problem. The most common chronic wounds can be
classified into three categories: venous ulcers, diabetic ulcers, and pressure ulcers.
Venous ulcers, which usually occur in the legs, account for about 70% to 90% of chronic
wounds and can become infected easily. Venous ulcers are sores that develop after
veins in the legs have been damaged. These ulcers can penetrate deeply into the skin.
Occasionally, if a venous ulcer persists for a long time, skin cancer might develop at the
edge. It has been shown that several bacteria species can colonize chronic wounds as
highly persistent biofilm communities. Chronic wound pathogenic biofilms are hostpathogen environments that colonize and exist as a cohabitation of many bacterial
species that cooperate to promote their own survival and the chronic nature of the
infection. Bacterial biofilms are highly organised microbial communities living within a
protective extracellular matrix. They are difficult to detect and highly resistant to immune
or antibiotic elimination. There are specific major populations of bacteria that are evident
in the biofilms of all chronic wound types. Species including Staphylococcus,
Pseudomonas, Peptoniphilus, Enterobacter, Stenotrophomonas, Finegoldia, and
Serratia spp are found to be common chronic wound pathogens.
Our preliminary studies have shown that non-toxic vitamins such as riboflavin
(vitamin B2) and cobalamin (vitamin B12) can produce singlet oxygen and free radicals
upon irradiation. Furthermore, our data has shown, upon irradiation with low energy
visible light, riboflavin and cobalamin both can cleave and damage native doublestranded DNA. It is very important to use low energy visible light in the process owing to
it penetrates human tissue much deeper then the high energy UV light. Also, visible light
will not damage normal human cells like UV light. The delivery of visible light is a
localized process normally using laser light transported by optical fibers. We have the
knowledge and technology to discover and develop the drugs as well as design a
portable laser system for PACT that can be patented and eventually commercialized.
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Introduction
The objective of this invention is to use photoactive vitamin nanoparticles as new
photodynamic antimicrobial chemotherapeutic agents to heal chronic wounds. Chronic
wounds are considered as a worldwide health problem due to the treatment being often
inadequate. Incorrect diagnosis, overuse of systemic antibiotics and inadequate use of
compression therapy frequently aggravate the complications.
It has been shown that several bacteria species can colonize chronic wounds as
highly persistent biofilm communities. Chronic wound pathogenic biofilms are hostpathogen co-exist environments that many bacterial species cohabitate to promote their
own survival. Many people have the misconception that systemic antibiotics alone can
treat these infections. However, the truth is that use of antibiotics alone is often harmful,
because they often breed bacteria that are resistant to the antibiotic being used. For
that reason, photodynamic antimicrobial chemotherapy (PACT) has the potential to
represent an alternative antibacterial, antifungal, and antiviral treatment for drugresistant microorganisms. It is very unlikely for any organisms to develop resistance to
cytotoxic reactive molecules such as reactive oxygen species (ROS) generated by the
photosensitizers. Our studies have shown that non-toxic vitamins such as riboflavin
(vitamin B6), phylloquinone (vitamin K1), and menaquinone (vitamin K2) are excellent
photosensitizes that can produce singlet oxygen and free radicals upon irradiation. We
have also developed a unique nano-emulsion to increase the solubility of these
otherwise hard to dissolve, hydrophobic vitamins for faster, more effective delivery to
the target cells. This invention will provide a novel photodynamic chemotherapeutic
regime for the treatment of chronic wound ulcers caused by microbial biofilms.
Photodynamic therapy (PDT) is a technique that uses the combination of light
and nontoxic drugs to destroy specific targeted cells.1-11 After the inactive and nontoxic
drug is applied topically or injected, it localizes in the selected tissue and can only be
activated by irradiation with certain wavelengths of light. When these photosensitive
drugs are activated, they can produce highly reactive intermediates and ultimately lead
to the selective death of targeted cells without affecting normal tissue. Currently, PDT is
being applied mostly in the treatment of cancer.2,4,6,8,9 However, several studies have
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shown that PDT can also be utilized in antimicrobial management.1,4,5,7 Research
interest in antimicrobial PDT diminished for many years due to the availability of
antibiotics. However, in recent years, the emergence of antibiotic-resistant bacterial
strains, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant
Enterococcus faecalis, has renewed interest in alternative treatments.
It has been established that there are specific major populations of bacteria that
are habited in all chronic wound biofilms. Species including Staphylococcus,
Pseudomonas, Peptoniphilus, Enterobacter, Stenotrophomonas, Finegoldia, and
Serratia spp are found to be common chronic wound pathogens.12 Bacterial biofilms are
highly organized microbial communities living within a protective extracellular matrix.
They are difficult to detect and highly resistant to immune or antibiotic elimination. It has
been suggested that biofilm presence may contribute to the intractable inflammatory
processes seen in chronic wounds. Several clinical studies showed there was a
statistically significant (p<0.001) that chronic wound patients had developed biofilms (>
60%) verses that of acute wound patients (6%). Molecular analyses of chronic wound
specimens have revealed the diverse polymicrobial communities and the presence of
bacterial colonization.13-15
Various metallic compounds have been investigated for their utility as PDT
agents, most notably cisplatin in the treatment of cancer.16 The primary problems with
cisplatin are its selective utility against various forms of cancer, its toxicity to human
cells, and the resistance that tumor cells may develop against it.16 Other metallic
compounds have been thoroughly investigated for their photoreactive properties and
their utility as PDT agents and, more specifically, PACT agents.17-25 While many suffer
from the same shortcomings as cisplatin, some do not have the same side effects;
however, all the metallic compounds suffer from problems related to synthesis. That is,
they have complex syntheses and may be costly to manufacture. Naturally occurring
compounds such as riboflavin and phylloquinone do not have the drawbacks associated
with synthesis. Naturally occurring compounds have the added benefit that they will not
harm normal tissue. That is, they remain inert until photoactivated, thus, they are great
candidates for PACT agents.
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Our research would eventually solve many of the major problems associated with
post-wound infections by developing a new, fully characterized treatment that is based
on well-known, inexpensive, and innocuous aqueous vitamin nanoparticles in
combination with light therapy.

Methods
DNA Photocleavage
The DNA photocleavage experiments were carried out on a 20 µL total sample volume
in 0.5 mL transparent Eppendorf microtubes containing 120 µM pUC19 plasmid and 30

µM of DAP in 10 mM phosphate buffer, 5 mM NaCl, pH = 7.5. All samples were
irradiated for 30 min after 30 minutes of incubation following addition of DAP. After
irradiation, the samples were loaded into the gel following the addition of 4 µL of DNA
gel loading solution to each reaction mixture. In showing the pH dependence of
photocleavage, the pH of each reaction mixture was varied using phosphate buffer
before adding DAP and irradiation. All the photolysis experiments were conducted in air
at room temperature. The electrophoresis was carried out using 2% agarose gel
stained with 0.5 mg/L ethidium bromide in 1X TAE running buffer (TAE = tris-acetate
EDTA) at 90 V for 1.5 hours, and the gels were imaged on a GelDoc 2000
transilluminator (Bio-Rad, Hercules, CA). The extent of photocleavage was calculated
from the ratio of nicked (circular) to supercoiled ds-DNA determined from the integration
of image intensity available in the QuantityOne Analysis System software (Bio-Rad,
Hercules, CA). In these measurements, no correction was made for the difference in
EtBr emission from the different forms of DNA.

Cytotoxicity and Photocytotoxicity Assays.
Human skin fibroblasts (Hs-27) were obtained from the American Type Culture
Collection, cell line CRL-1634 (Manassas, VA). The cells were cultured in Dulbecco’s
Modified Eagle Media, containing 10% fetal bovine serum, 50 µg/mL gentamicin, 4.5
4

mg/mL glucose, and 4 mM L-glutamine. The cell cultures were incubated in a
humidified atmosphere containing 5% CO2 at 37 oC.
For assessing the cytotoxicity and photocytotoxicity of nanoparticles, >80%
confluent monolayers of Hs-27 in 60 mm culture dishes were used. The monolayers
were first washed twice with phosphate-buffered saline (PBS) to ensure that the culture
dishes were free of any culture medium. Fresh PBS (3 mL) containing various
concentrations of DAP was then added to cover the fibroblasts. The cells were
irradiated through the PBS buffer, which does not absorb light in the visible region,
immediately without an incubation period. The spectral output of the visible light was
~2.8 x 10–3 W/cm2, and all samples were irradiated no longer than 30 min (~5 J/cm2)
at room temperature. Following irradiation, the cells were removed from the dishes by
trypsinization, reseeded into 24-well culture dishes, and incubated for 48 hours. Nlauroyl sarcosine (200 µL, 40 mM) was then added to each well and the cells were
allowed to lyse for at least 30 min. Quantitative determination of the protein content in
each well was undertaken using Peterson's modification of the micro-Lowry method.
The lysate was treated with 200 µL Lowry reagent for 30 min and then with 100 µL
Folin-Ciocalteau phenol reagent for 30 min. A portion (200 µL) of the contents of each
well was transferred to a 96-well plate for absorbance determination using a 96 well
MRX plate reader (Dynatech Laboratory, DynPort, VA). The absorbance measured at
630 nm is proportional to the total protein content and the number of cells in each well.
Nanoemulsion:
Due to most photoactive vitamins in nature being either hydrophobic or low in
solubility, we have developed a biocompatible nano-emulsion in order to deliver
lipophilic vitamins to target cells more effectively. We used high a HLB (hydrophiliclipophilic balance) emulsifier to prepare our oil in water nanoparticles. Tween 20 has a
HLB of 16.7 which serves as the emulsifier. We use vitamin F (mixture of linoleic acid
and alpha linoleic acid) as our primary fatty acid which has a HLB of 14-15. It meets the
criteria of HLB for solubilizing oil in water to make clear nanoemulsion. HLB value needs
to be in between13-18.
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Making Emulsion:
Oil

16%

Emulsifier

4%

Water

80%

Primary Emulsion:
Vitamin F with vitamin

4 Parts

Water

2 Parts

Tween 20 (Emulsifier)

1 Part

Hydrophobic vitamin was dissolved in fatty acid (vitamin F) by vortexing in a
centrifuge tube. Then one part of Tween 20 and 2 parts (v/v) of water were added to it
and vortexed for 5 min. This primary emulsion was sonicated for 1 hour in Brason 2500
sonifier. This primary emulsion was diluted 1:10 to avoid aggregation and Tween 20
was added drop by drop to make clear emulsion. It was again sonicated for additional
30 minutes to reduce the particle size and get a clear emulsion.

Results
Our data has shown that riboflavin not only has an excellent DNA binding
constant (K b > 104 M-1). Shown in Figure 1, it can also cleave DNA under irradiation
with visible light (λ > 395 nm). A singlet oxygen study using 9,10-anthracene
dipropinoic acid (ADPA) as the singlet oxygen sensor has shown that riboflavin is
capable of producing a large quantity of singlet oxygen after only 15 minutes of
irradiation (Figure2).
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Figure1:

Figure 2:
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Figure 3: TEM image of vitamin K encapsulated nanoparticles.
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Figure4: Riboflavin solubility increased more than 3 fold by using nanoemulsion.
Picture on the left shows riboflavin precipitation in water at 250 µM, picture on the right
shows clear solution at 750 µM.

Antibacterial study has shown that after one hour incubation and 30 minutes
irradiation with low intensity light (about 5J/cm2), a concentration of riboflavin as low as
85 mg/Kg can cause 50% bacteria fatality. Compare with the acute oral toxicity
recorded on the official MSDS of LD50 > 10g/Kg. Therefore, needless to say, the
concentration used for eradicating bacteria would have no effect to the normal human
cells. The same result was also obtained in the phylloquinone study. Table 1 shows the
complete summary of our bacterial study with LD50 values in mg/Kg.
Table 1: LD50 (lethal dose 50 in mg/Kg) of riboflavin and phylloquinone in both
irradiated and dark conditions. Acute oral systematic toxicity of both was cited
from the official MSDS.
Human Skin

E coli

Acute Oral
Toxicity

Dark

Irradiated

Dark

Irradiated

Riboflavin

No Effect

2,100

197

85

> 10,000

Phylloquinone

No Effect

18,779

1,100

423

25,000
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Conclusion
Our research will provide significant improvement to heal chronic wounds by
using non-expensive, non-toxic photoactive vitamin nanoparticles as new photodynamic
antimicrobial chemotherapeutic agents. The expense in lost manpower, hospitalizations,
debilitation, and even death is costly globally. Conventional methods of killing bacteria
(such as antibiotics and disinfection) are often ineffective due to increasing rates of
multidrug resistance and can cause additional damage to surrounding tissue, thus
inhibiting recovery and overall successful surgical outcomes. The huge doses of
antimicrobials required to treat patients who are already immunosuppressed are
medically undesirable, and are increasingly ineffective. As a result, new strategies are
urgently needed for immediate use and PACT has proven to be the solution. In
addition, spin-off applications of this work would offer opportunities for other
environmental friendly uses such as bioremediating hazardous waste sites, biofiltering
industrial water, and forming biobarriers to protect soil and groundwater from
contamination
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